Burden, access, and disparities in kidney disease

for the World Kidney Day Steering Committee

Research output: Contribution to journalArticle

Abstract

Introduction Kidney disease is a global public health problem that affects more than 750 million persons worldwide.1 The burden of kidney disease varies substantially across the world, as does its detection and treatment. Although the magnitude and impact of kidney disease is better defined in developed countries, emerging evidence suggests that developing countries have a similar or even greater kidney disease burden.2 In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors, leading to significant disparities in disease burden, even in developed countries.3 These disparities exist across the spectrum of kidney disease-from preventive efforts to curb development of acute kidney injury (AKI) or chronic kidney disease (CKD), to screening for kidney disease among persons at high risk, to access to subspecialty care and treatment of kidney failure with renal replacement therapy (RRT). World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. In this editorial, we highlight these disparities and emphasize the role of public policies and organizational structures in addressing them. We outline opportunities to improve our understanding of disparities in kidney disease, the best ways for them to be addressed, and how to streamline efforts toward achieving kidney health equity across the globe.

Original languageEnglish (US)
Pages (from-to)131-137
Number of pages7
JournalExperimental and Clinical Transplantation
Volume17
Issue number2
DOIs
StatePublished - Apr 1 2019

Fingerprint

Kidney Diseases
Kidney
Renal Replacement Therapy
Politics
Public Policy
Treatment Failure
Chronic Renal Insufficiency
Acute Kidney Injury
Developed Countries
Developing Countries
Renal Insufficiency
Public Health

Keywords

  • Acute kidney injury
  • End stage renal disease
  • Global health
  • Health equity
  • Social determinants of health

ASJC Scopus subject areas

  • Transplantation

Cite this

Burden, access, and disparities in kidney disease. / for the World Kidney Day Steering Committee.

In: Experimental and Clinical Transplantation, Vol. 17, No. 2, 01.04.2019, p. 131-137.

Research output: Contribution to journalArticle

for the World Kidney Day Steering Committee 2019, 'Burden, access, and disparities in kidney disease', Experimental and Clinical Transplantation, vol. 17, no. 2, pp. 131-137. https://doi.org/10.6002/ect.2019.wkde
for the World Kidney Day Steering Committee. / Burden, access, and disparities in kidney disease. In: Experimental and Clinical Transplantation. 2019 ; Vol. 17, No. 2. pp. 131-137.
@article{18952cfa9f6441968972e6980d65b46e,
title = "Burden, access, and disparities in kidney disease",
abstract = "Introduction Kidney disease is a global public health problem that affects more than 750 million persons worldwide.1 The burden of kidney disease varies substantially across the world, as does its detection and treatment. Although the magnitude and impact of kidney disease is better defined in developed countries, emerging evidence suggests that developing countries have a similar or even greater kidney disease burden.2 In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors, leading to significant disparities in disease burden, even in developed countries.3 These disparities exist across the spectrum of kidney disease-from preventive efforts to curb development of acute kidney injury (AKI) or chronic kidney disease (CKD), to screening for kidney disease among persons at high risk, to access to subspecialty care and treatment of kidney failure with renal replacement therapy (RRT). World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. In this editorial, we highlight these disparities and emphasize the role of public policies and organizational structures in addressing them. We outline opportunities to improve our understanding of disparities in kidney disease, the best ways for them to be addressed, and how to streamline efforts toward achieving kidney health equity across the globe.",
keywords = "Acute kidney injury, End stage renal disease, Global health, Health equity, Social determinants of health",
author = "{for the World Kidney Day Steering Committee} and Crews, {Deidra C.} and Bello, {Aminu K.} and Gamal Saadi and Li, {Philip Kam Tao} and Guillermo Garcia-Garcia and Sharon Andreoli and Deidra Crews and Kamyar Kalantar-Zadeh and Charles Kernahan and Latha Kumaraswami and Luisa Strani",
year = "2019",
month = "4",
day = "1",
doi = "10.6002/ect.2019.wkde",
language = "English (US)",
volume = "17",
pages = "131--137",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
publisher = "Baskent University",
number = "2",

}

TY - JOUR

T1 - Burden, access, and disparities in kidney disease

AU - for the World Kidney Day Steering Committee

AU - Crews, Deidra C.

AU - Bello, Aminu K.

AU - Saadi, Gamal

AU - Li, Philip Kam Tao

AU - Garcia-Garcia, Guillermo

AU - Andreoli, Sharon

AU - Crews, Deidra

AU - Kalantar-Zadeh, Kamyar

AU - Kernahan, Charles

AU - Kumaraswami, Latha

AU - Strani, Luisa

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Introduction Kidney disease is a global public health problem that affects more than 750 million persons worldwide.1 The burden of kidney disease varies substantially across the world, as does its detection and treatment. Although the magnitude and impact of kidney disease is better defined in developed countries, emerging evidence suggests that developing countries have a similar or even greater kidney disease burden.2 In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors, leading to significant disparities in disease burden, even in developed countries.3 These disparities exist across the spectrum of kidney disease-from preventive efforts to curb development of acute kidney injury (AKI) or chronic kidney disease (CKD), to screening for kidney disease among persons at high risk, to access to subspecialty care and treatment of kidney failure with renal replacement therapy (RRT). World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. In this editorial, we highlight these disparities and emphasize the role of public policies and organizational structures in addressing them. We outline opportunities to improve our understanding of disparities in kidney disease, the best ways for them to be addressed, and how to streamline efforts toward achieving kidney health equity across the globe.

AB - Introduction Kidney disease is a global public health problem that affects more than 750 million persons worldwide.1 The burden of kidney disease varies substantially across the world, as does its detection and treatment. Although the magnitude and impact of kidney disease is better defined in developed countries, emerging evidence suggests that developing countries have a similar or even greater kidney disease burden.2 In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors, leading to significant disparities in disease burden, even in developed countries.3 These disparities exist across the spectrum of kidney disease-from preventive efforts to curb development of acute kidney injury (AKI) or chronic kidney disease (CKD), to screening for kidney disease among persons at high risk, to access to subspecialty care and treatment of kidney failure with renal replacement therapy (RRT). World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. In this editorial, we highlight these disparities and emphasize the role of public policies and organizational structures in addressing them. We outline opportunities to improve our understanding of disparities in kidney disease, the best ways for them to be addressed, and how to streamline efforts toward achieving kidney health equity across the globe.

KW - Acute kidney injury

KW - End stage renal disease

KW - Global health

KW - Health equity

KW - Social determinants of health

UR - http://www.scopus.com/inward/record.url?scp=85064239370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064239370&partnerID=8YFLogxK

U2 - 10.6002/ect.2019.wkde

DO - 10.6002/ect.2019.wkde

M3 - Article

C2 - 30945627

AN - SCOPUS:85064239370

VL - 17

SP - 131

EP - 137

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

IS - 2

ER -